Logo image of ISRG

INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis

NASDAQ:ISRG - Nasdaq - US46120E6023 - Common Stock - Currency: USD

526.15  -30.93 (-5.55%)

After market: 525.851 -0.3 (-0.06%)

Fundamental Rating

7

Overall ISRG gets a fundamental rating of 7 out of 10. We evaluated ISRG against 188 industry peers in the Health Care Equipment & Supplies industry. ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ISRG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, ISRG could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ISRG had positive earnings in the past year.
In the past year ISRG had a positive cash flow from operations.
In the past 5 years ISRG has always been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

ISRG has a better Return On Assets (12.88%) than 95.21% of its industry peers.
ISRG's Return On Equity of 14.47% is amongst the best of the industry. ISRG outperforms 90.96% of its industry peers.
ISRG has a Return On Invested Capital of 12.56%. This is amongst the best in the industry. ISRG outperforms 94.68% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 7.89%.
The 3 year average ROIC (12.30%) for ISRG is below the current ROIC(12.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.88%
ROE 14.47%
ROIC 12.56%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)12.3%
ROIC(5y)11.92%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 28.41%, ISRG belongs to the best of the industry, outperforming 96.81% of the companies in the same industry.
In the last couple of years the Profit Margin of ISRG has declined.
With an excellent Operating Margin value of 28.28%, ISRG belongs to the best of the industry, outperforming 97.34% of the companies in the same industry.
In the last couple of years the Operating Margin of ISRG has declined.
ISRG has a better Gross Margin (67.09%) than 72.34% of its industry peers.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 28.28%
PM (TTM) 28.41%
GM 67.09%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ISRG is creating some value.
The number of shares outstanding for ISRG has been increased compared to 1 year ago.
Compared to 5 years ago, ISRG has more shares outstanding
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 58.45 indicates that ISRG is not in any danger for bankruptcy at the moment.
ISRG has a better Altman-Z score (58.45) than 100.00% of its industry peers.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 58.45
ROIC/WACC1.37
WACC9.15%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

ISRG has a Current Ratio of 4.98. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
ISRG has a Current ratio of 4.98. This is in the better half of the industry: ISRG outperforms 73.94% of its industry peers.
ISRG has a Quick Ratio of 3.97. This indicates that ISRG is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.97, ISRG is doing good in the industry, outperforming 72.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.98
Quick Ratio 3.97
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.76% over the past year.
The Earnings Per Share has been growing by 11.48% on average over the past years. This is quite good.
Looking at the last year, ISRG shows a quite strong growth in Revenue. The Revenue has grown by 19.08% in the last year.
Measured over the past years, ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%

3.2 Future

ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.45% yearly.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 68.87, which means the current valuation is very expensive for ISRG.
Compared to the rest of the industry, the Price/Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 66.49% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ISRG to the average of the S&P500 Index (26.53), we can say ISRG is valued expensively.
A Price/Forward Earnings ratio of 57.04 indicates a quite expensive valuation of ISRG.
Based on the Price/Forward Earnings ratio, ISRG is valued a bit cheaper than 63.83% of the companies in the same industry.
ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.27.
Industry RankSector Rank
PE 68.87
Fwd PE 57.04
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

64.36% of the companies in the same industry are more expensive than ISRG, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 70.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 108.05
EV/EBITDA 64.41
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
ISRG's earnings are expected to grow with 13.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.79
PEG (5Y)6
EPS Next 2Y12.18%
EPS Next 3Y13.88%

More info and screens

0

5. Dividend

5.1 Amount

ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTUITIVE SURGICAL INC

NASDAQ:ISRG (6/9/2025, 8:00:02 PM)

After market: 525.851 -0.3 (-0.06%)

526.15

-30.93 (-5.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-16 2025-07-16/amc
Inst Owners89.44%
Inst Owner Change0.6%
Ins Owners0.5%
Ins Owner Change5.97%
Market Cap188.58B
Analysts79.49
Price Target593.43 (12.79%)
Short Float %1.36%
Short Ratio2.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)-1.03%
PT rev (3m)-9.13%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)-2.19%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 68.87
Fwd PE 57.04
P/S 21.64
P/FCF 108.05
P/OCF 69.05
P/B 11.02
P/tB 11.27
EV/EBITDA 64.41
EPS(TTM)7.64
EY1.45%
EPS(NY)9.22
Fwd EY1.75%
FCF(TTM)4.87
FCFY0.93%
OCF(TTM)7.62
OCFY1.45%
SpS24.31
BVpS47.73
TBVpS46.7
PEG (NY)7.79
PEG (5Y)6
Profitability
Industry RankSector Rank
ROA 12.88%
ROE 14.47%
ROCE 13.94%
ROIC 12.56%
ROICexc 17.02%
ROICexgc 17.52%
OM 28.28%
PM (TTM) 28.41%
GM 67.09%
FCFM 20.03%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)12.3%
ROIC(5y)11.92%
ROICexc(3y)22.09%
ROICexc(5y)21.23%
ROICexgc(3y)23.21%
ROICexgc(5y)22.47%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 185.49%
Cap/Sales 11.31%
Interest Coverage 250
Cash Conversion 91.16%
Profit Quality 70.49%
Current Ratio 4.98
Quick Ratio 3.97
Altman-Z 58.45
F-Score6
WACC9.15%
ROIC/WACC1.37
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%